Clinical trial
Coronary Angioplasty With Sirolimus Drug-coated Stent System to Treat Patients With Symptomatic Ischemic Coronary Heart Disease: a PMCF Study.
NCT06621524 is registered in ClinicalTrials.gov with OrbusNeich as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Coronary Angioplasty With Sirolimus Drug-coated Stent System to Treat Patients With Symptomatic Ischemic Coronary Heart Disease: a PMCF Study.
- Lead sponsor
- OrbusNeich
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- March 14, 2025
- Completion date
- January 31, 2029
- Enrollment
- 251 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
coronary arterioscleroses